Skip to Content
Here’s what to ask a doctor about hereditary angioedema

Fluocinolone / hydroquinone / tretinoin topical Pregnancy and Breastfeeding Warnings

Fluocinolone / hydroquinone / tretinoin topical is also known as: Tri-Luma

Fluocinolone / hydroquinone / tretinoin topical Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. US FDA pregnancy category: C Comments: -If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential harm to the fetus. -Adverse events may be more likely with exposure during organogenesis in the first trimester.

Animal models have revealed evidence of in utero deaths, increased numbers of stillborn pups, decreased fetal weights, delayed preputial separation, and teratogenicity (e.g., cleft palate, protruding tongue, open eyes, umbilical hernia, retinal folding/dysplasia). Animal models given tretinoin or fluocinolone have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Fluocinolone / hydroquinone / tretinoin topical Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes (fluocinolone); Unknown (hydroquinone, tretinoin) Comments: -The effects in the nursing infant are unknown. -If this drug is used during breastfeeding, patients should ensure that infants do not come into contact with treated areas.

See references

References for pregnancy information

  1. "Product Information. Tri-Luma (fluocinolone/hydroquinone/tretinoin topical)." Galderma Laboratories Inc, Fort Worth, TX.

References for breastfeeding information

  1. "Product Information. Tri-Luma (fluocinolone/hydroquinone/tretinoin topical)." Galderma Laboratories Inc, Fort Worth, TX.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.